Day 4 and day 0 neutrophil‐to‐lymphocyte ratios as predictors of treatment failure with single‐dose methotrexate for ectopic pregnancies
International Journal of Gynecology & Obstetrics · 2024
DOI: 10.1002/ijgo.15248 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Rukeyemu Abuduxukuer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, School of Medicine, Shanghai First Maternity and Infant Hospital, Tong Ji University, Shanghai, P.R. China. Hauptthemen laut MEDLINE: Abortifacient Agents, Nonsteroidal, Pregnancy, Ectopic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Science and Technology Innovation Plan Of Shanghai Science and Technology Commission.
Abstract (Originalsprache)
Objective
To evaluate changes in the neutrophil‐to‐lymphocyte ratio (NLR) between day 4 and day 0 in ectopic pregnancy (EP) patients treated with single‐dose methotrexate (MTX) and investigate its predictive value for treatment outcome.
Methods
A total of 406 EP patients receiving single‐dose MTX therapy at Shanghai First Maternity and Infant Hospital from January 10, 2013 to September 30, 2019 were studied. A multivariate model was constructed to predict treatment outcome.
Results
Among the 406 patients, 281 were treated successfully. Treatment success declined significantly when NLR decreased by less than 23% (74.8% vs 58.5%, P = 0.004). Multivariate regression analysis identified NLR reduction of less than 23% on day 4 (odds ratio [OR] 2.09, 95% confidence interval [CI] 1.27–3.44), a human chorionic gonadotropin (hCG) decrease of 15% or less (OR 3.17, 95% CI 1.62–6.34), and an hCG increase of more than 15% on day 4 (OR 5.47, 95% CI 3.05–10.22) as independent risk factors for single‐dose MTX treatment failure. The final predictive model had a sensitivity of 0.768 and a specificity of 0.569, using a cut‐off value of 3. The area under the receiver operating characteristic curve was 0.712. Patients with a predictive score of ≥3 were more likely to fail single‐dose MTX therapy.
Conclusion
The present study concluded that an NLR decrease of less than 23% on day 4, a plateau or increase in serum hCG on day 4, and an hCG value greater than 1000 mIU/mL on day 0 were predictors of single‐dose MTX treatment failure in EP patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, School of Medicine, Shanghai First Maternity and Infant Hospital, Tong Ji University, Shanghai, P.R. China.
- Shanghai Key Laboratory of Maternal and Fetal Medicine, Shanghai First Maternity and Infant Hospital, Shanghai, P.R. China.
- Department of Clinical Research Center, School of Medicine, Shanghai First Maternity and Infant Hospital, Tong Ji University, Shanghai, P.R. China.
ORCID-Profile: Xiaoyue Chen
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Abuduxukuer, R., Chen, X., Ni, J., Li, S., & Lu, W. (2024). Day 4 and day 0 neutrophil‐to‐lymphocyte ratios as predictors of treatment failure with single‐dose methotrexate for ectopic pregnancies. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15248
Vancouver
Abuduxukuer R, Chen X, Ni J, Li S, Lu W. Day 4 and day 0 neutrophil‐to‐lymphocyte ratios as predictors of treatment failure with single‐dose methotrexate for ectopic pregnancies. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15248
BibTeX
@article{Abuduxukuer2024,
author = {Abuduxukuer, Rukeyemu and Chen, Xiaoyue and Ni, Jingyi and Li, Shuangdi and Lu, Wen},
title = {Day 4 and day 0 neutrophil‐to‐lymphocyte ratios as predictors of treatment failure with single‐dose methotrexate for ectopic pregnancies},
journal = {International Journal of Gynecology & Obstetrics},
year = {2024},
doi = {10.1002/ijgo.15248}
}
EUVIMED